C1q blocks aberrant effector CD8+ T cell responses by recognizing activated CD8+ T cells through globular structural domains and affecting their mitochondrial metabolism, and such aberrant effector CD8+ T cells are known to be involved in the development of systemic lupus erythematosus (SLE) (27). The gene discussed is CD8A; the disease is systemic lupus erythematosus.